Achieve Life Sciences Shares Fall After FDA Inspection Finds Violations

Dow Jones
04/15

By Christopher Kuo

 

Achieve Life Sciences shares fell after the Food and Drug Administration found that one of its third-party facilities requires regulatory or administrative action.

Shares of the pharmaceutical company fell 5.1% on Wednesday to $3.43. Achieve Life's shares are down 31% year to date.

After inspecting one of the company's third-party manufacturing facilities, the FDA designated the facility under its most severe classification category, Official Action Indicated, which often means a facility is not compliant with regulations.

Achieve Life said the FDA classification is related to manufacturing practices at the facility and not to its drug, cytisinicline.

 

Write to Christopher Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

April 15, 2026 11:33 ET (15:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10